NasdaqGM - Nasdaq Real Time Price USD
Acrivon Therapeutics, Inc. (ACRV)
1.1300
-0.0700
(-5.83%)
At close: May 13 at 4:00:01 PM EDT
1.1699
+0.04
+(3.53%)
After hours: May 13 at 7:54:44 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.61M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.34 - 1.41 per share. | Indirect | 1,017,919 | May 1, 2025 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.41 - 1.95 per share. | Indirect | 2,744,946 | Apr 29, 2025 |
| DEVROE ERIC Chief Operating Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 10,400 | May 17, 2024 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.50 per share. | Indirect | 20,000,500 | Apr 11, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 8.50 per share. | Indirect | 30,005,000 | Apr 11, 2024 |
| MILLER MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 26, 2023 |
| BLUME-JENSEN PETER Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 21, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.93 per share. | Indirect | 207 | Jun 26, 2023 |
| HOLM-JORGENSEN RASMUS Chief Financial Officer | Conversion of Exercise of derivative security at price 3.63 per share. | Direct | 34,485 | Jun 16, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.14 per share. | Indirect | 24,960 | Jun 15, 2023 |
| CHIONE, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.13 - 12.34 per share. | Indirect | 72,412 | Jun 14, 2023 |
| DEVROE ERIC Chief Operating Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 9,594 | Jun 5, 2023 |
| BLUME-JENSEN PETER Chief Executive Officer | Conversion of Exercise of derivative security at price 3.88 per share. | Direct | 130,387 | May 31, 2023 |
Related Tickers
ARTV Artiva Biotherapeutics, Inc.
2.0500
-2.38%
CCCC C4 Therapeutics, Inc.
1.5000
-5.06%
PEPG PepGen Inc.
1.5300
+1.32%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2100
-6.20%
ABOS Acumen Pharmaceuticals, Inc.
1.0500
0.00%
OBIO Orchestra BioMed Holdings, Inc.
2.9400
+10.94%
HOOK HOOKIPA Pharma Inc.
1.3700
+2.24%
LXEO Lexeo Therapeutics, Inc.
2.8300
+7.60%
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%
RLMD Relmada Therapeutics, Inc.
0.3900
-2.08%